Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing budesonide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide systemic preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide adverse reaction |
Causative agent (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Topical budesonide adverse reaction |
Causative agent (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Allergy to budesonide (finding) |
Causative agent (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Topical budesonide allergy |
Causative agent (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide [gastro-intestinal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 3mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 2mg/100mL enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 400micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 500micrograms/2mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 1mg/2mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide refill 100dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide refill 200dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 50micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 100micrograms aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide Topical |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Product containing budesonide in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Product containing budesonide in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Product containing budesonide in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide refill |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 50mcg/dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 0.5mg/2mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 7g inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 32micrograms aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200mcg/spray powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 32mcg/spray spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 0.25mg/2mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200micrograms inhaler with spacer device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide refill 100dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide refill 200dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 50micrograms aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 64mcg aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200mcg dry powder cartridge and refillable inhaler device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Product containing budesonide and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 80mcg/formoterol 4.5mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 160mcg/formoterol 4.5mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 320mcg/formoterol 9mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200micrograms inhaler with spacer device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 200mcg dry powder cartridge refill |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide+eformoterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide+eformoterol fumarate 200/6mcg breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide + formoterol fumarate 100/6mcg breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide+eformoterol fumarate dihydrate 400micrograms/12micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 90micrograms dry powder for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 180micrograms dry powder for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Allergy to budesonide (finding) |
Causative agent (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Topical budesonide allergy |
Causative agent (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 50 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Budesonide 64mcg conventional release nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
|
Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 100 microgram/actuation nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 100 microgram/actuation nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Budesonide (substance) |
Inferred relationship |
Some |
2 |
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
2 |
Budesonide 400 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 400 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Budesonide (substance) |
Inferred relationship |
Some |
2 |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
2 |
Budesonide 100 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 100 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing budesonide in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing budesonide and formoterol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide and formoterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide and formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing only budesonide in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing only budesonide in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing only budesonide in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 50 microgram/actuation nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 50 microgram/actuation nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram/actuation solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram/actuation solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Budesonide (substance) |
Inferred relationship |
Some |
1 |